Regulus Therapeutics Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

RGLS has 69.23 million shares outstanding. The number of shares has increased by 199.52% in one year.

Current Share Class	n/a
Shares Outstanding	69.23M
Shares Change (YoY)	+199.52%
Shares Change (QoQ)	+1.03%
Owned by Insiders (%)	2.02%
Owned by Institutions (%)	60.81%
Float	62.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.31, with a Debt / Equity ratio of 0.02.

Current Ratio	16.31
Quick Ratio	14.87
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-550.55

Financial Efficiency

Return on equity (ROE) is -53.82% and return on invested capital (ROIC) is -35.91%.

Return on Equity (ROE)	-53.82%
Return on Assets (ROA)	-34.23%
Return on Invested Capital (ROIC)	-35.91%
Return on Capital Employed (ROCE)	-73.48%
Revenue Per Employee	n/a
Profits Per Employee	-$1.40M
Employee Count	34
Asset Turnover	n/a
Inventory Turnover	11.15

Taxes

In the past 12 months, RGLS has paid $1,000 in taxes.

Income Tax	1,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +225.10% in the last 52 weeks. The beta is 0.37, so RGLS's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	+225.10%
50-Day Moving Average	6.65
200-Day Moving Average	2.76
Relative Strength Index (RSI)	66.62
Average Volume (20 Days)	2,586,472

Short Selling Information

The latest short interest is 2.09 million, so 3.02% of the outstanding shares have been sold short.

Short Interest	2.09M
Short Previous Month	1.91M
Short % of Shares Out	3.02%
Short % of Float	3.32%
Short Ratio (days to cover)	1.57

Income Statement

Revenue	n/a
Gross Profit	-36.15M
Operating Income	-51.75M
Pretax Income	-35.39M
Net Income	-47.52M
EBITDA	-51.40M
EBIT	-51.75M
Earnings Per Share (EPS)	-$0.72

Full Income Statement

Balance Sheet

The company has $65.37 million in cash and $1.40 million in debt, giving a net cash position of $63.97 million or $0.92 per share.

Cash & Cash Equivalents	65.37M
Total Debt	1.40M
Net Cash	63.97M
Net Cash Per Share	$0.92
Equity (Book Value)	69.03M
Book Value Per Share	1.04
Working Capital	67.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$43.54 million and capital expenditures -$111,000, giving a free cash flow of -$43.66 million.

Operating Cash Flow	-43.54M
Capital Expenditures	-111,000
Free Cash Flow	-43.66M
FCF Per Share	-$0.63

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RGLS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-199.52%
Shareholder Yield	-199.52%
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

The average price target for RGLS is $8.50, which is 4.17% higher than the current price. The consensus rating is "Buy".

Price Target	$8.50
Price Target Difference	4.17%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 29, 2022. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jun 29, 2022
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1